ResearcherThe University of SydneyNo recent work listed
Terence C. Chua
Matched on ORCID iD 0000-0002-4263-1017; OpenAlex author ID A5061945795. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper
Papers 8
- Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy. First author DOI 10.1016/j.ejso.2021.04.005↗
- Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1097/mpa.0000000000001472↗
- Pancreatoduodenectomy With Arterial Resection for Locally Advanced Pancreatic Cancer of the Head: A Systematic Review. First author DOI 10.1097/mpa.0000000000001551↗
- Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: analysis of early outcome data. Co-author DOI 10.1111/ans.13897↗
- Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume r… Co-author DOI 10.1016/j.ejso.2017.06.012↗
- Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis. Co-author DOI 10.18632/oncotarget.19928↗
- Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1371/journal.pone.0150338↗
- Preoperative chemoradiation followed by surgical resection for resectable pancreatic cancer: a review of current results. Co-author DOI 10.1016/j.suronc.2011.05.003↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jaswinder Singh Samra · 7 shared papers, 2016–2021 · strength 0.61
- Paper Pancreatoduodenectomy With Arterial Resection for Locally Advanced Pancreatic Cancer of the Head: A Systematic Review. DOI 10.1097/mpa.0000000000001551↗
- Paper Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of … DOI 10.1016/j.ejso.2021.04.005↗
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Anthony James Gill · 7 shared papers, 2016–2021 · strength 0.61
- Paper Pancreatoduodenectomy With Arterial Resection for Locally Advanced Pancreatic Cancer of the Head: A Systematic Review. DOI 10.1097/mpa.0000000000001551↗
- Paper Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of … DOI 10.1016/j.ejso.2021.04.005↗
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Anubhav Mittal · 6 shared papers, 2017–2021 · strength 0.56
- Paper Pancreatoduodenectomy With Arterial Resection for Locally Advanced Pancreatic Cancer of the Head: A Systematic Review. DOI 10.1097/mpa.0000000000001551↗
- Paper Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of … DOI 10.1016/j.ejso.2021.04.005↗
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Nick Pavlakis · 4 shared papers, 2017–2021 · strength 0.35
- Paper Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of … DOI 10.1016/j.ejso.2021.04.005↗
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Paper Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: an… DOI 10.1111/ans.13897↗
- Nigel Balfour Jamieson · 3 shared papers, 2020–2021 · strength 0.34
- Paper Pancreatoduodenectomy With Arterial Resection for Locally Advanced Pancreatic Cancer of the Head: A Systematic Review. DOI 10.1097/mpa.0000000000001551↗
- Paper Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of … DOI 10.1016/j.ejso.2021.04.005↗
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Christopher Bahdah Nahm · 4 shared papers, 2017–2021 · strength 0.34
- Paper Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of … DOI 10.1016/j.ejso.2021.04.005↗
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Paper Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review … DOI 10.18632/oncotarget.19928↗
- Stephen John Clarke · 3 shared papers, 2017–2021 · strength 0.26
- Paper Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of … DOI 10.1016/j.ejso.2021.04.005↗
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Paper Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic … DOI 10.1016/j.ejso.2017.06.012↗
- George Hruby · 3 shared papers, 2017–2021 · strength 0.26
- Paper Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of … DOI 10.1016/j.ejso.2021.04.005↗
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Paper Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic … DOI 10.1016/j.ejso.2017.06.012↗
- Malinda Itchins · 2 shared papers, 2017–2020 · strength 0.15
- Paper Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreati… DOI 10.1097/mpa.0000000000001472↗
- Paper Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic … DOI 10.1016/j.ejso.2017.06.012↗
- Morgan Haines · 1 shared paper, 2020 · strength 0.13
- Sarah Maloney · 1 shared paper, 2021 · strength 0.11
- David Lok Hang Chan · 1 shared paper, 2021 · strength 0.11
- Asanka Rohan Wijetunga · 1 shared paper, 2021 · strength 0.11
- Phil Townend · 1 shared paper, 2018 · strength 0.09
- David Stephenson · 1 shared paper, 2017 · strength 0.08
- Michael Tayao · 1 shared paper, 2016 · strength 0.06
- Akshat Saxena · 1 shared paper, 2011 · strength 0.06
- Matthew H. Wong · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.